tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Rani Therapeutics Holdings Inc

RANI
Add to Watchlist
0.758USD
-0.009-1.17%
Market hours 09/24, 13:05（ET）
103.29MMarket Cap
LossP/E TTM

Rani Therapeutics Holdings Inc

0.758
-0.009-1.17%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

RANI Financials

See Rani Therapeutics Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
103.29M
Dividend TTM
0.00
P/E TTM
-2.80
EPS TTM
-0.27
Revenue
1.63M
Net Profit
-30.02M
ROE
-232.29%
ROA
-95.33%

Rani Therapeutics Holdings Inc Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
-0.04/-0.05
Revenue / Forecast
1.71M/925.00K

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
78.44%-0.04
82.01%-0.04
74.55%-0.07
50.46%-0.12
29.16%-0.18
24.43%-0.22
0.22%-0.27
34.65%-0.24
29.57%-0.26
13.35%-0.29
22.20%-0.27
---0.36
---0.37
---0.33
---0.35
---0.93
----
----
----
----
Revenue
--1.71M
893.02%1.71M
42.12%1.46M
--0.00
--0.00
--172.00K
--1.03M
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
Net Profit
-10.45%-7.39M
3.18%-7.03M
-15.18%-10.30M
20.21%-5.41M
1.66%-6.69M
2.93%-7.26M
-26.05%-8.95M
26.25%-6.78M
26.85%-6.80M
10.62%-7.48M
19.21%-7.10M
-15.61%-9.20M
-22.02%-9.30M
-34.53%-8.37M
-69.32%-8.79M
-153.18%-7.96M
-39.00%-7.62M
-11.16%-6.22M
9.85%-5.19M
-8.98%-3.14M
Net Margin
---493.03%
93.66%-469.26%
59.39%-621.08%
----
----
---7405.81%
---1529.38%
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
--100.00%
0.00%100.00%
0.00%100.00%
----
----
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
-100.00%0.00%
105.38%133.51%
51.14%101.96%
57.63%86.72%
32.44%67.19%
56.16%65.01%
92.49%67.46%
81.66%55.01%
88.01%50.73%
--41.63%
--35.04%
--30.28%
--26.98%
--13.02%
----
----
----
----
Income Statement
Revenue
--1.71M
893.02%1.71M
42.12%1.46M
--0.00
--0.00
--172.00K
--1.03M
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
Operating profit
15.96%-8.83M
30.58%-8.34M
24.09%-8.54M
38.49%-7.26M
16.12%-10.51M
14.40%-12.01M
16.30%-11.24M
33.92%-11.80M
31.54%-12.52M
15.03%-14.03M
23.16%-13.43M
-9.26%-17.86M
-15.44%-18.29M
-19.85%-16.52M
-30.83%-17.48M
41.18%-16.34M
-201.39%-15.85M
-165.10%-13.78M
-170.27%-13.36M
-882.70%-27.78M
Net Profit
-10.45%-7.39M
3.18%-7.03M
-15.18%-10.30M
20.21%-5.41M
1.66%-6.69M
2.93%-7.26M
-26.05%-8.95M
26.25%-6.78M
26.85%-6.80M
10.62%-7.48M
19.21%-7.10M
-15.61%-9.20M
-22.02%-9.30M
-34.53%-8.37M
-69.32%-8.79M
-153.18%-7.96M
-39.00%-7.62M
-11.16%-6.22M
9.85%-5.19M
-8.98%-3.14M
Balance Sheet
Current assets
410.46%56.52M
164.81%47.09M
79.27%53.32M
-84.69%4.96M
-65.43%11.07M
-57.04%17.78M
-41.50%29.74M
-48.80%32.37M
-58.06%32.03M
-53.51%41.39M
-49.62%50.85M
-37.23%63.22M
-22.06%76.37M
-18.51%89.04M
-15.61%100.92M
-23.91%100.72M
41.04%97.99M
42.26%109.26M
--119.59M
--132.37M
Total current liabilities
-48.42%10.64M
-31.17%13.86M
-36.31%12.67M
-5.28%19.14M
24.38%20.62M
50.50%20.13M
148.98%19.89M
175.17%20.21M
189.12%16.58M
159.71%13.38M
65.92%7.99M
2.21%7.34M
7.22%5.74M
23.92%5.15M
82.39%4.81M
36.88%7.19M
-42.82%5.35M
-41.35%4.16M
--2.64M
--5.25M
Total assets
260.06%60.84M
115.04%51.88M
60.02%58.62M
-76.71%10.14M
-61.35%16.90M
-54.92%24.13M
-36.75%36.63M
-38.19%43.54M
-47.64%43.73M
-44.52%53.51M
-46.39%57.92M
-34.90%70.44M
-19.97%83.51M
-16.36%96.45M
-13.03%108.03M
-21.00%108.20M
34.95%104.34M
40.49%115.31M
--124.21M
--136.96M
Total liabilities
-50.64%12.86M
-44.57%16.34M
-48.38%17.11M
-41.45%22.11M
-31.76%26.05M
-24.38%29.47M
2.06%33.14M
6.03%37.77M
8.03%38.18M
11.82%38.98M
-4.56%32.47M
64.93%35.62M
521.05%35.34M
647.20%34.86M
1188.75%34.02M
311.33%21.59M
-42.88%5.69M
-50.97%4.67M
--2.64M
--5.25M
Total equity
624.25%47.98M
764.48%35.54M
1088.43%41.51M
-307.32%-11.97M
-264.92%-9.15M
-136.80%-5.35M
-86.27%3.49M
-83.41%5.78M
-88.48%5.55M
-76.40%14.54M
-65.62%25.44M
-59.80%34.82M
-51.17%48.17M
-44.34%61.59M
-39.12%74.00M
-34.24%86.61M
46.46%98.65M
52.48%110.64M
--121.57M
--131.71M
Cash Flow Statement
Net operating income
-55.73%-9.03M
20.27%-6.50M
103.40%294.00K
39.80%-5.06M
35.81%-5.80M
13.33%-8.15M
30.64%-8.65M
41.20%-8.41M
26.60%-9.03M
22.64%-9.40M
14.70%-12.48M
-17.26%-14.30M
-19.10%-12.30M
-29.85%-12.15M
-27.78%-14.63M
-9.69%-12.20M
-83.51%-10.33M
-131.23%-9.36M
-70.88%-11.45M
-1759.70%-11.12M
Net investment
-354.79%-14.56M
-113.44%-2.45M
-1328.56%-30.97M
-100.00%0.00
-12.44%5.71M
77.08%18.23M
-81.01%2.52M
-95.98%469.00K
727.00%6.53M
149.67%10.29M
3004.60%13.27M
116.36%11.67M
308.18%789.00K
1723.23%4.12M
-68.63%-457.00K
---71.35M
-178.68%-379.00K
-156.57%-254.00K
-5.86%-271.00K
--0.00
Net financing
9903.19%18.81M
99.28%-27.00K
698.22%44.85M
-113.10%-1.01M
33.33%188.00K
-3183.47%-3.73M
5753.13%5.62M
15622.45%7.70M
76.25%141.00K
1412.50%121.00K
-99.35%96.00K
-99.65%49.00K
63.27%80.00K
--8.00K
2709.47%14.87M
-80.32%14.08M
103.09%49.00K
-100.00%0.00
-100.83%-570.00K
2472.78%71.55M

FAQs

What is the total revenue of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its total revenue reached 1.63M, with a year-on-year change of 1.03M.

What are the current assets of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its current assets were 53.32M, with a year-on-year change of 79.27.

What are the total assets of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its total assets of Rani Therapeutics Holdings Inc were 58.62M, with a year-on-year change of 60.02.

What are the total liabilities of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its total liabilities of Rani Therapeutics Holdings Inc were 17.11M, with a year-on-year change of -48.38.

What is the total equity of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its total equity of Rani Therapeutics Holdings Inc was 41.51M, with a year-on-year change of 1088.43.

What is the net operating income of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net operating income of Rani Therapeutics Holdings Inc was -38.31M, with a year-on-year change of 22.76.

What is the net investment of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net investment of Rani Therapeutics Holdings Inc was -7.03M, with a year-on-year change of -135.49.

What is the net financing of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net financing of Rani Therapeutics Holdings Inc was 40.30M, with a year-on-year change of 196.65.

What is the Earnings Per Share (EPS) of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.45, with a year-on-year change of 57.44.

What is the net income of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net income was -29.67M, with a year-on-year change of 1.15.

What is the net margin of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its net profit margin was -2507.65, with a year-on-year change of 54.44.

What is the Return on Equity (ROE) of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -169.55, with a year-on-year change of 58.04.

What is the Return on Assets (ROA) of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -85.98, with a year-on-year change of 28.17.

What is the operating profit of Rani Therapeutics Holdings Inc?

According to Rani Therapeutics Holdings Inc's FY2025 earnings report, its operating profit was -38.31M, with a year-on-year change of 22.76.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy